EICHOR
● Completed
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)
Condition: Gout · Arthritis, Gouty · Hyperuricemia · Sponsor: Arthrosi Therapeutics
About this study
This study will assess the serum uric acid lowering effect and safety of AR882 in gout patients at two doses compared to placebo over 12 months
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (68)
| Arthrosi Investigative Site (106) | Foley, Alabama, United States | — |
| Arthrosi Investigative Site (139) | Anchorage, Alaska, United States | — |
| Arthrosi Investigative Site (160) | Peoria, Arizona, United States | — |
| Arthrosi Investigative Site (112) | Phoenix, Arizona, United States | — |
| Arthrosi Investigative Site (114) | Tempe, Arizona, United States | — |
| Arthrosi Investigative Site (131) | El Cajon, California, United States | — |
| Arthrosi Investigative Site (117) | Encinitas, California, United States | — |
| Arthrosi Investigative Site (138) | Rancho Cucamonga, California, United States | — |
| Arthrosi Investigative Site (161) | Valencia, California, United States | — |
| Arthrosi Investigative Site (101) | Aurora, Colorado, United States | — |
| Arthrosi Investigative Site (149) | Clearwater, Florida, United States | — |
| Arthrosi Investigative Site (115) | Coral Gables, Florida, United States | — |
+ 56 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06439602